These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

550 related items for PubMed ID: 27888614

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Prognostic value of programmed death ligand 1, p53, and Ki-67 in patients with advanced-stage colorectal cancer.
    Wang L, Liu Z, Fisher KW, Ren F, Lv J, Davidson DD, Baldridge LA, Du X, Cheng L.
    Hum Pathol; 2018 Jan; 71():20-29. PubMed ID: 28782638
    [Abstract] [Full Text] [Related]

  • 23. [Significance of COX-2, p53, proliferating cell nuclear antigen and nm23 expressions in gastric cancer and its behavior].
    Ji SQ, Hua YW, Zhuang J, Gao Y, Kong Y, Han SL, Shao YF.
    Ai Zheng; 2002 Jun; 21(6):619-24. PubMed ID: 12452062
    [Abstract] [Full Text] [Related]

  • 24. High cyclooxygenase-2 expression is associated with advanced stages in colorectal cancer.
    Elzagheid A, Emaetig F, Alkikhia L, Buhmeida A, Syrjänen K, El-Faitori O, Latto M, Collan Y, Pyrhönen S.
    Anticancer Res; 2013 Aug; 33(8):3137-43. PubMed ID: 23898071
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Immunoexpression of TS, p53, COX2, EGFR, MSH6 and MLH1 biomarkers and its correlation with degree of differentiation, tumor staging and prognostic factors in colorectal adenocarcinoma: a retrospective longitudinal study.
    Batista WR, Santos G, Vital FMR, Matos D.
    Sao Paulo Med J; 2019 May 08; 137(1):33-38. PubMed ID: 31116268
    [Abstract] [Full Text] [Related]

  • 27. Nuclear Y-Box-binding Protein-1 Expression Predicts Poor Clinical Outcome in Stage III Colorectal Cancer.
    Shiraiwa S, Kinugasa T, Kawahara A, Mizobe T, Ohchi T, Yuge K, Fujino S, Katagiri M, Shimomura S, Tajiri K, Sudo T, Kage M, Kuwano M, Akagi Y.
    Anticancer Res; 2016 Jul 08; 36(7):3781-8. PubMed ID: 27354655
    [Abstract] [Full Text] [Related]

  • 28. NM23 protein expression in colorectal carcinoma using TMA (tissue microarray): association with metastases and survival.
    Oliveira LA, Artigiani-Neto R, Waisberg DR, Fernandes LC, Lima Fde O, Waisberg J.
    Arq Gastroenterol; 2010 Jul 08; 47(4):361-7. PubMed ID: 21225146
    [Abstract] [Full Text] [Related]

  • 29. Lack of correlation between epidermal growth factor receptor status and response to Panitumumab monotherapy in metastatic colorectal cancer.
    Hecht JR, Mitchell E, Neubauer MA, Burris HA, Swanson P, Lopez T, Buchanan G, Reiner M, Gansert J, Berlin J.
    Clin Cancer Res; 2010 Apr 01; 16(7):2205-13. PubMed ID: 20332321
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Maspin and Nm23-H1 expression in colorectal cancer.
    Pasz-Walczak G, Salagacka A, Potemski P, Balcerczak E, Kordek R, Mirowski M.
    Neoplasma; 2010 Apr 01; 57(2):95-101. PubMed ID: 20099971
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.
    Theodoropoulos GE, Karafoka E, Papailiou JG, Stamopoulos P, Zambirinis CP, Bramis K, Panoussopoulos SG, Leandros E, Bramis J.
    Anticancer Res; 2009 Feb 01; 29(2):785-91. PubMed ID: 19331236
    [Abstract] [Full Text] [Related]

  • 35. The high expression of p53 in sporadic colorectal carcinoma is associated with metastasis and decreased survival.
    Pancione M, Forte N, Campione S, Napolitano A, Parente D, Sabatino L, Febbraro A, Colantuoni V.
    Pathologica; 2010 Apr 01; 102(2):51-6. PubMed ID: 23596757
    [Abstract] [Full Text] [Related]

  • 36. Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer.
    Lee KE, Lee HJ, Kim YH, Yu HJ, Yang HK, Kim WH, Lee KU, Choe KJ, Kim JP.
    Jpn J Clin Oncol; 2003 Apr 01; 33(4):173-9. PubMed ID: 12810831
    [Abstract] [Full Text] [Related]

  • 37. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer.
    Sarli L, Bader G, Iusco D, Salvemini C, Mauro DD, Mazzeo A, Regina G, Roncoroni L.
    Eur J Cancer; 2005 Jan 01; 41(2):272-9. PubMed ID: 15661553
    [Abstract] [Full Text] [Related]

  • 38. Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma.
    Chang SC, Lin JK, Lin TC, Liang WY.
    Int J Oncol; 2005 Jan 01; 26(1):65-75. PubMed ID: 15586226
    [Abstract] [Full Text] [Related]

  • 39. Clinical significance of perineural invasion in stages II and III colorectal cancer.
    Zhou Y, Wang H, Gong H, Cao M, Zhang G, Wang Y.
    Pathol Res Pract; 2015 Nov 01; 211(11):839-44. PubMed ID: 26429129
    [Abstract] [Full Text] [Related]

  • 40. [Overexpression of c-erbB-2 and hypoexpression of nm23 relating to poor prognosis of colorectal carcinoma].
    Zhang JB, Chen L, Han F, Yu L, He S, Zhou JY.
    Zhonghua Bing Li Xue Za Zhi; 2003 Apr 01; 32(2):115-9. PubMed ID: 12839671
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.